ABUS Earnings

Quarterly EPS
$-0.10
Q3 2024
$-0.07
Q4 2024
$-0.13
Q1 2025
$0.01
Q2 2025
$-0.04
Q3 2025
$-0.02
Q4 2025
$0.88
Q1 2026
$-0.03
Q2 2026
Latest Revenue1.0M
Latest Net Income-5192000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.031.0M-5192000-90.6%-400.0%
Q1 2026$0.88179.1M169.7M+10,054.5%+776.9%
Q4 2025-$0.021.1M-3756000-33.2%+71.4%
Q3 2025-$0.04529.0K-7742000-60.5%+60.0%
Q2 2025$0.0110.7M2.5M+522.2%+109.1%
Q1 2025-$0.131.8M-24526000+15.1%-30.0%
Q4 2024-$0.071.6M-12532000-26.6%+36.4%
Q3 2024-$0.101.3M-19717000-71.3%+16.7%
Q2 2024-$0.111.7M-19796000
Q1 2024-$0.101.5M-17875000
Q4 2023-$0.112.1M-19312000
Q3 2023-$0.124.7M-20104000
Arbutus Biopharma (ABUS) — Earnings